Patients' perspectives on smoking and inflammatory bowel disease
Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations
August, 2020
Awareness Raising
Biosimilar knowledge and viewpoints among Brazilian inflammatory bowel disease patients
Biosimilar knowledge and viewpoints among Brazilian inflammatory bowel disease patients
August, 2020
In this analysis we aimed to describe Brazilian inflammatory bowel disease (IBD) patients’ knowledge and perceptions regarding biosimilars and compare with viewpoints from non-Brazilian patients.
Views of patients with inflammatory bowel disease on the COVID-19 pandemic: a global survey
Views of patients with inflammatory bowel disease on the COVID-19 pandemic: a global survey
World IBD Day 2020
Make IBD work!
19 May World IBD Day – Awareness raising campaign
Quality of Care Standards in Inflammatory Bowel Diseases
Quality of Care Standards in Inflammatory Bowel Diseases: a European Crohn’s and Colitis Organisation [ECCO] Position Paper
February, 2020
The Future of Biosimilars
The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases
February, 2020
The Socioeconomic Impact of Living With Ulcerative Colitis
43 The Socioeconomic Impact of Living With Ulcerative Colitis: A Burden of Illness Study
October, 2019
The living with Ulcerative Colitis (UC), identifying the socioeconomic burden in Europe (LUCID) study was a descriptive, retrospective, cross-sectional, European, multi-site, bottom-up Burden of Illness research study carried out by HCD Economics and the University of Chester in partnership with Crohn's and Colitis UK.
The Impact of Ulcerative Colitis on Quality of Life and Productivity Across Europe
744 The Impact of Ulcerative Colitis on Quality of Life and Productivity Across Europe: A Burden of Illness Study
October, 2019
Changes in inflammatory bowel disease patients’ perspectives on biosimilars
Changes in inflammatory bowel disease patients’ perspectives on biosimilars: A follow-up survey
October, 2019
The aim of this survey was to find out whether the perspectives of patients with inflammatory bowel disease concerning biosimilars have changed since the publication of our last survey carried out in 2014–2015.
Nurses are Critical in Aiding Patients Transitioning to Biosimilars in Inflammatory Bowel Disease
Nurses are Critical in Aiding Patients Transitioning to Biosimilars in Inflammatory Bowel Disease: Education and Communication Strategies
October, 2018